Approval · Notice of Compliance 19567 · 2017
FLECAINIDE: Notice of Compliance 19567
Issued July 24, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19567
- Date
- July 24, 2017
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Canadian reference product
- TAMBOCOR (3M Pharmaceuticals, A Division Of 3M Canada Company)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLECAINIDE | Not yet assigned | — |
Medicinal ingredients
- FLECAINIDE ACETATE 50 MG per TAB
- FLECAINIDE ACETATE 100 MG per TAB